跳至主要内容
临床试验/NCT06746857
NCT06746857尚未招募不适用

iTBS-Neurosplasticity for Female Youth With Depression

University of British Columbia0 个研究点目标入组 8 人开始时间: 2026年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
8
主要终点
Hamilton Rating Scale Depression

研究概览

简要总结

TBC

详细描述

TBs

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 24 Years(Child, Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •are assigned female sex at birth;
  • •are 16yo to 24yo;
  • •outpatients;
  • •are competent to assent (those age 16-18) or consent to participate (those age 19-24);
  • •have a Diagnostic and Statistical Manual of Mental Disorders Fifth edition (DSM 5) diagnosis of Major Depressive Episode by Mini-International Neuropsychiatric Interview (MINI) version 7.0.0 for participants aged 18-24 and Adolescents (MINI-KID) for participants aged 16-17;
  • •have a score ≥ 18 on the Hamilton Depression Rating Scale (HDRS-17 item) or Depressive symptom severity as shown by a total Children's Depression Rating Scale Revised (CDRS-R) score 40;
  • •have not changed dose or initiated a new regular antidepressant or antidepressant augmentation treatment(s) for 4 weeks prior to starting TMS treatment;
  • •are able to adhere to the treatment schedule;
  • •pass both the TMS and MRI adult safety screening questionnaires.

排除标准

  • •have Moderate or Severe Substance Use Disorder (except tobacco) within the last three (3) months;
  • •have a concomitant major unstable medical illness;
  • •have active suicidal intent;
  • •have not responded to 2 or more adequate trials of antidepressant medication in the current episode as meassured by the ATHF form
  • •are pregnant or planning to become pregnant during the study period;
  • •have a lifetime (MINI) diagnosis of any psychotic disorder;
  • •have a MINI anxiety disorder or personality disorder assessed by a study investigator to be primary and causing greater impairment than MDE;
  • •have previously had ECT or rTMS;
  • •have any significant neurological disorder or any significant head trauma with clear radiological evidence of cerebrovascular injury on imaging.
  • •have any intracranial implant (e.g., aneurysm clips) or any other metal object within or near the head, excluding the mouth, that cannot be safely removed;
  • •have history of epilepsy
  • •are participating in standardized regular psychotherapy provided by a psychiatrist or a registered psychologist for less than 3 months prior to study entry or planning to start during the course of rTMS treatments;
  • •have a clinically significant laboratory abnormality, in the opinion of the one of the principal investigators;
  • •have a non-correctable clinically significant sensory impairment (i.e., cannot hear well enough to cooperate with interview);

研究组 & 干预措施

Accelerated iTBS

Experimental

干预措施: repetitive transcranial magnetic stimulation (Device)

结局指标

主要结局

Hamilton Rating Scale Depression

时间窗: Four weeks

Minimum score: 0; Maximum score: 52; higher scores mean worse outcome.

Hamilton Rating Scale Depression

时间窗: Four weeks

Minimum score: 0; Maximum score: 52; higher scores mean worse outcome.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fidel Vila-Rodriguez, MD, PhD, FRCPC, DFAPA

Associate Professor

University of British Columbia

相似试验